(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl (2E,4E,6E,8E)-9-[(2-{2-[2-({[3-(benzyloxy)phenyl]methyl}amino)ethoxy]ethoxy}ethyl)carbamoyl]nona-2,4,6,8-tetraenoate
Structure Info
- Chemspace ID
- CSCS20591796731 (Synthesis)
- IUPAC Name
- (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl (2E,4E,6E,8E)-9-[(2-{2-[2-({[3-(benzyloxy)phenyl]methyl}amino)ethoxy]ethoxy}ethyl)carbamoyl]nona-2,4,6,8-tetraenoate
- Mol formula
- C46H60N2O9
- Mol weight
- 785 Da
- Catalog Number(s)
- BD02669112, HY-161742, T88725
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 6.3
- Heavy atoms count
- 57
- Rotatable bond count
- 25
- Number of rings
- 5
- Carbon bond saturation, Fsp3
- 0.47826086956522
- Polar surface area (Å)
- 129
- Hydrogen bond acceptors count
- 9
- Hydrogen bond donors count
- 2
- Zoom the structure
- CSCS20591796731
Items Overall 5 items from 3 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BLD Pharmatech Co., Limited | 30 days | United States To: | 95 | 1 mg | 1,338.00 | |
Description: Name:(3R,4S,5S,6R)-5-Methoxy-4-((2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl)-1-oxaspiro[2.5]octan-6-yl (13E,15E,17E,19E)-1-(3-(benzyloxy)phenyl)-12-oxo-5,8-dioxa-2,11-diazahenicosa-13,15,17,19-tetraen-21-oate; CAS: 2410081-58-0 | ||||||
| BLD Pharmatech GmbH | 30 days | Germany To: | 95 | 1 mg | 1,338.00 | |
Description: Name:(3R,4S,5S,6R)-5-Methoxy-4-((2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl)-1-oxaspiro[2.5]octan-6-yl (13E,15E,17E,19E)-1-(3-(benzyloxy)phenyl)-12-oxo-5,8-dioxa-2,11-diazahenicosa-13,15,17,19-tetraen-21-oate; CAS: 2410081-58-0 | ||||||
| Targetmol Chemicals Inc | 30 days | United States To: | 90 | 25 mg | 3,320.00 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 90 | 50 mg | 4,380.00 | |
| Targetmol Chemicals Inc | 30 days | United States To: | 90 | 100 mg | 6,100.00 | |
Description: Fumagilin-105, an autophagy-targeting chimera (AUTOTAC), induces self-oligomerization of p62 and exhibits a DC50 of 0.7 μM against MetAP2 in HEK293 cells.; CAS: 2410081-58-0 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire